Mr Neal A Fischbach, MD in Trumbull, CT - Medicare Medical Oncology

Mr Neal A Fischbach, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Trumbull, Connecticut. He went to Harvard Medical School and graduated in 1995 and has 29 years of diverse experience with area of expertise as Medical Oncology. He is a member of the group practice Yale University and his current practice location is 15 Corporate Drive, Trumbull, Connecticut. You can reach out to his office (for appointments etc.) via phone at (203) 459-0262.

Mr Neal A Fischbach is licensed to practice in Connecticut (license number 042999) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1588758718.

Contact Information

	Mr Neal A Fischbach, MD
	15 Corporate Drive, Trumbull, CT 06611
	(203) 459-0262
	(203) 459-0264

Physician's Profile

Full Name	Mr Neal A Fischbach
Gender	Male
Speciality	Medical Oncology
Experience	29 Years
Location	15 Corporate Drive, Trumbull, Connecticut
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mr Neal A Fischbach attended and graduated from Harvard Medical School in 1995

NPI Data:

NPI Number: 1588758718
Provider Enumeration Date: 10/03/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 4880621432
Enrollment ID: I20050726000066

Medical Identifiers

Medical identifiers for Mr Neal A Fischbach such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588758718	NPI	-	NPPES
2V6556	Other		HEALTHNET
P3597961	Other		OXFORD
010042999CT01	Other	CT	ANTHEM
001429994	Medicaid	CT

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	042999 (Connecticut)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Yale-new Haven Hospital	New haven, CT	Hospital
Bridgeport Hospital	Bridgeport, CT	Hospital
Greenwich Hospital Association -	Greenwich, CT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Yale University	9436061736	2241

News Archive

Personalized treatment approach may benefit patients with common breast cancer subtype

The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.

A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability

Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mr Neal A Fischbach allows following entities to bill medicare on his behalf.

Entity Name	Yale University
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015

News Archive

Personalized treatment approach may benefit patients with common breast cancer subtype

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability

Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Neal A Fischbach is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Neal A Fischbach, MD 15 Corporate Drive, Trumbull, CT 06611 Ph: (203) 459-0262	Mr Neal A Fischbach, MD 15 Corporate Drive, Trumbull, CT 06611 Ph: (203) 459-0262

News Archive

Personalized treatment approach may benefit patients with common breast cancer subtype

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability

Researchers tested the vaccine candidate in mice with up to three doses and found it produces high levels of antibodies against both SARS-CoV-2 variants of concern and the original virus strain.

Internal Medicine Doctors in Trumbull, CT

Dawn Lukose, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd Ste 220, Trumbull, CT 06611 Phone: 203-374-6162
Geny Ann George, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 115 Technology Dr Ste 101, Trumbull, CT 06611 Phone: 203-372-7200
Daniel G. Sica, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 888 White Plains Rd, Suite 203, Trumbull, CT 06611 Phone: 203-459-0408 Fax: 203-459-0410
Joseph A Evangelista, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15 Corporate Dr, #2-2, Trumbull, CT 06611 Phone: 203-268-8673
Dr. Molain Saintilus, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd, Suite 220, Trumbull, CT 06611 Phone: 203-374-6162 Fax: 203-374-1549
Linda S Werner, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 115 Technology Dr Unit C101, Trumbull, CT 06611 Phone: 203-372-7200 Fax: 203-374-1473
Dr. William G. Hulcher, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 888 White Plains Rd, Suite 202, Trumbull, CT 06611 Phone: 203-459-9666 Fax: 203-459-9698

Mr Neal A Fischbach, MD - Medicare Medical Oncology in Trumbull, CT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Personalized treatment approach may benefit patients with common breast cancer subtype

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability

Medicare Reassignments

Personalized treatment approach may benefit patients with common breast cancer subtype

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Personalized treatment approach may benefit patients with common breast cancer subtype

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Scientists uncover how primary protein responsible for multidrug resistance reacts to therapeutic drugs

A SARS-CoV-2 vaccine candidate based on B.1.351 spike trimer shows broad neutralizing capability

Internal Medicine Doctors in Trumbull, CT